The Valley Desk

ArticleFrontiers in oncologyPublished

ERBB family fusions are recurrent and actionable oncogenic targets across cancer types

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Frontiers in oncology
Published
Subject terms
Gene fusion; EGFR; Oncogene; erbB2; 500 Erbb Family Fusions Across Cancer Types; Erbb4 Words: 3
PubMed ID
37168365
PubMed Central ID
PMC10164992
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal